30 results
8-K/A
EX-10.1
CHRS
Coherus Biosciences Inc
21 May 24
Financial Statements and Exhibits
5:14pm
Adverse Change, Borrower and each of its Subsidiaries has implemented and maintains a commercially reasonable data privacy and information security
8-K/A
EX-10.2
CHRS
Coherus Biosciences Inc
21 May 24
Financial Statements and Exhibits
5:14pm
Section 4.18
Insurance
Section 4.19
ERISA Compliance
Section 4.20
Labor Matters
Section 4.21
Taxes
Section 4.22
Data Privacy
ARTICLE 5
REPRESENTATIONS … Obligations
Section 7.19
Products
Section 7.20
Anti-Corruption Laws.
Section 7.21
Data Privacy
ARTICLE 8
INDEMNIFICATION
Section 8.1
General
8-K
EX-2.1
dxi61imrb2su6
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
424B3
ry58nger
26 Jul 23
Prospectus supplement
4:59pm
S-4/A
1qd4xava
24 Jul 23
Registration of securities issued in business combination transactions (amended)
4:42pm
S-4
70mxf1j83xry4 rt5w
7 Jul 23
Registration of securities issued in business combination transactions
5:03pm
8-K
EX-1.1
3ndf9ccpfky9bmm cjt8
18 May 23
Other Events
5:02pm
8-K
EX-10.1
n7jdj0za
7 Jan 22
Coherus BioSciences Secures Credit Financing
8:36am